Guggenheim also raised its price target on CytomX Therapeutics to $15 from $10 and kept a ‘Buy’ rating on the shares.

TrumpRx drug prices aren’t the world’s lowest, says a new report comparing Wegovy and more to Germany and other nations. Read ...

Pfizer PFE is one of the leading oncology drugmakers with a strong presence across breast, genitourinary, thoracic, gastrointestinal and blood cancers. The company has a well-established portfolio of ...

The very first patient would receive the first clinical doses of HMBD-001, the first cancer treatment from Hummingbird ...

After a significant ruling from the Supreme Court of Appeal, prostate cancer patients in South Africa can continue to access ...

The TrumpRx website claims to offer the best prices for medications. Here’s where Americans still pay more — and much more.

Pharmacy benefit managers act as middlemen between drugmakers, insurers, pharmacies and patients and are accused of selling marked-up medicine.

Strikes on Iran disrupt Gulf air cargo, forcing pharmaceutical companies to reroute medicines through Saudi Arabia, Oman, and ...

Pharmacy benefit managers (PBMs) have used market leverage to demand rebates, which can lead drug manufacturers to increase ...

Price transparency compliance is often “in-form” rather than “in-spirit,” with many machine-readable files failing to provide ...

The stock now trades at a dividend yield of 6.5%. Despite continued pricing pressure, Pfizer stock looks cheap for investors ...

More than 1 in 4 U.S. adults struggle to afford their prescription medications. Those who can't are left with grim choices—such as skipping doses, cutting pills in half, or abandoning prescriptions ...